Embecta Corp (EMBC)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $366.02M
Last updated: Nov 17, 2026 at 4:15 PM ET
Embecta Corp (EMBC) Stock Chart
Embecta (EMBC) has a latest price of $6.15 on Nov 17, 2026, 57.1% below its 52-week high of $14.33. Its price fell 56.4% over the past 12 months. The month-end price fell 58.7% over the 3 years through Oct 2026, a compound annual decline of 25.5%.
Price Chart
From Apr 2022 to Oct 2026, its highest month-end close was $32.92 in Nov 2022 and its lowest $3.26 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EMBC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EMBC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 13.7%, and over 6 months it rose 113.1%.
| Period | Change |
|---|---|
| 1 month | -1.0% |
| 3 months | +13.7% |
| 6 months | +113.1% |
| 12 months | -56.4% |
| 12 months, with dividends | -54.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -58.7% | -25.5% |
Price by Year
Its best calendar year was 2024, when the price rose 9.1%, and its weakest was 2025, when it fell 42.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $6.25 | -47.4% |
| 2025 | $11.88 | -42.5% |
| 2024 | $20.65 | +9.1% |
| 2023 | $18.93 | -25.1% |
Trading Range
The price is 2.7% above its 50-day average of $5.99 and 0.7% above its 200-day average of $6.11.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.15 | |
| 52-week high | $14.33 | -57.1% |
| 52-week low | $2.76 | +123.1% |
| 50-day average | $5.99 | +2.7% |
| 200-day average | $6.11 | +0.7% |
Price Risk
Over 3 years, its largest fall from a peak was 85.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.46 |
| Largest fall, 1 year | -79.7% |
| Largest fall, 3 years | -85.3% |
Valuation
Embecta traded at 3.9x earnings at the end of 2025, against a 5-year median of 5.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EMBC
What is EMBC's 1-year price change?
Embecta's price fell 56.4% over the past 12 months. With dividends included, the 12-month total return was -54.2%.
How has EMBC stock done over the long term?
Embecta's month-end price fell 58.7% over the 3 years through Oct 2026, a compound annual decline of 25.5%. These figures leave out dividends.
What is EMBC's 52-week high and low?
Embecta's 52-week high is $14.33 and its 52-week low is $2.76. Its latest price of $6.15 on Nov 17, 2026 is 57.1% below the high.
What is EMBC's beta?
Embecta's 1-year beta against the S&P 500 is 0.46, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 79.7%.
Is the EMBC chart free?
Yes. Advanced Charting for EMBC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EMBC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors